Skip to main content
创远信科 logo

创远信科 — Investor Relations & Filings

Ticker · 920961 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 657 across all filing types
Latest filing 2025-12-10 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920961

About 创远信科

https://www.transcom.net.cn/

Transcom Instruments specializes in the research, development, and manufacturing of high-end wireless communication testing and measurement equipment. The company provides a comprehensive suite of solutions including vector network analyzers, signal generators, spectrum analyzers, and wireless network optimization tools. Its product portfolio serves critical sectors such as telecommunications, aerospace, defense, and automotive electronics. Transcom is recognized for its expertise in RF and microwave technology, offering advanced testing capabilities for 5G and emerging 6G standards. By focusing on independent innovation, the company delivers high-precision instruments and integrated testing systems designed to ensure the reliability and performance of wireless infrastructure and mobile devices.

Recent filings

Filing Released Lang Actions
关于本次交易构成重大资产重组和关联交易但不构成重组上市的说明
Regulatory Filings Classification · 95% confidence The document is an official announcement by the company 创远信科 (Shanghai) Technology Co., Ltd. regarding a significant transaction involving the purchase of 100% equity of another company and related financing. It discusses the classification of the transaction as a major asset restructuring and related party transaction, referencing specific regulatory rules such as the "Listing Company Major Asset Restructuring Management Measures" and the Beijing Stock Exchange listing rules. The document includes financial data comparisons and legal compliance statements. It is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about the nature of the transaction and its compliance with relevant laws. The document length is relatively short (2398 characters) and it serves as a formal disclosure of the transaction's classification and compliance, fitting the profile of a Regulatory Filing (RNS) rather than a full report or detailed financial statement.
2025-12-10 Chinese
关于本次交易履行法定程序的完备性、合规性及提交的法律文件的有效性的说明
Regulatory Filings Classification · 95% confidence The document is a detailed announcement by the company about the completeness, compliance, and validity of legal documents related to a major asset acquisition transaction involving issuance of shares and cash payment. It references various regulatory laws and procedures, stock suspension and resumption notices, board meetings, independent director opinions, and legal and financial advisor reports. The document does not contain financial statements or detailed financial data but rather focuses on procedural compliance and legal validity of the transaction documents. It is not a full financial report, earnings release, or management discussion. It is also not a simple announcement of a report publication but a substantive compliance and procedural disclosure related to a major asset restructuring. This fits best under the category of Regulatory Filings (RNS), which is the fallback for regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-12-10 Chinese
关于本次交易相关主体不存在《上市公司监管指引第7号——上市公司重大资产重组相关股票异常交易监管》第十二条规定情形的说明
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding a major asset restructuring transaction involving the acquisition of 100% equity of another company. It references regulatory guidelines related to major asset restructurings and confirms that the transaction parties do not fall under prohibited conditions for participation. The document is short (839 characters) and serves as a compliance and regulatory disclosure about the transaction status rather than the transaction details or financial results themselves. It does not contain financial statements or detailed financial analysis. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-12-10 Chinese
国泰海通证券股份有限公司关于创远信科（上海）技术股份有限公司本次交易产业政策和交易类型的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's opinion on a major asset restructuring transaction involving issuance of shares and cash payment to acquire 100% equity of a target company. It references regulatory guidelines from the China Securities Regulatory Commission and industry classification codes. The document discusses the nature of the transaction, industry classification, whether it constitutes a backdoor listing, issuance of shares, and regulatory compliance. It is not a full annual or interim financial report, nor an earnings release or call transcript. It is a specialized advisory opinion related to a capital transaction and restructuring. This fits best under Capital/Financing Update (CAP) as it provides an update and opinion on a significant financing and acquisition transaction involving issuance of shares and cash payment, with regulatory compliance checks. The document length is 2525 characters, which is substantive and not a mere announcement or certification, so it is not RPA or RNS.
2025-12-10 Chinese
简式权益变动报告书（冠至沁和、长沙矢量）
Share Issue/Capital Change Classification · 87% confidence The document is a formal “简式权益变动报告书” under Chinese securities disclosure rules, detailing a multi‐party share issuance (new A‐shares) and cash payment to acquire 100% equity of a target and the resulting changes in shareholder percentages. This is not a simple earnings release, management report, or proxy statement, but a corporate action announcing new share issues and capital structure changes. Hence it fits the Share Issue/Capital Change category.
2025-12-10 Chinese
关于取得专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a patent certificate. It includes details about the patent type, patent number, and the impact of the patent on the company. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. The document is an official announcement about intellectual property achievements, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a corporate event (patent acquisition). Given the absence of a more specific category for patent announcements, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2025-11-30 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.